On October 24, 2016, the US Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS) announced the full implementation and indefinite extension of the Program for ...
Off-patent medicines provide people with access to high-quality essential treatment options that can be significantly less expensive than branded on-patent medicines. Off-patent therapies — generics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results